What's in the Trump-Pfizer deal aimed at lowering drug prices

Trump announced that Pfizer has agreed to offer lower prices on its drugs to the Medicaid program and directly to patients.

September 30, 2025 Check out STAT+

Sponsored By

Win McNamee/Getty Images Trump strikes deal with Pfizer aimed at lowering prescription drug prices Pfizer to price some drugs in line with costs in other countries, participate in new direct-to-consumer website, and avoid tariffs. By Daniel Payne and Matthew Herper Home hospital programs in 'terror' as they grind to halt ahead of government shutdown Hundreds of hospital at home programs are shutting down as Medicare's pandemic-era waiver nears expiration, straining ERs and patient care nationwide. By Mario Aguilar Push to create functional human eggs in the lab stumbles, pioneering fertility researcher reports Fertility pioneer Shoukhrat Mitalipov reports, after mouse success, there's long way to go in humans. 'We will figure it out,' scientist says By Megan Molteni Keystone Features/Getty Image Opinion: The Trump administration's Soviet approach to autism policy In a strangely Soviet turn, U.S. scientific and public health leadership subordinate their reasoned judgment on autism to the president's political needs. By Ari Ne'eman STAT+ | Lilly's head scientist discusses its GLP-1 pill, Alzheimer's strategy, and finding promising ideas and startups Q&A with Eli Lilly chief scientific officer Daniel Skovronsky on weight loss drugs, Alzheimer's, and importance of healthy biotech ecosystem By Jonathan Wosen Indivior to stop marketing Opvee, controversial overdose-reversal medication Indivior halts Opvee promotion after NY settlement. Critics say the overdose drug is overpriced, risky, and no safer than widely used naloxone. By Lev Facher Adobe Opinion: What is the price of saving a single child's life? Is it ethical to perform a high-risk surgery to save one infant in a country where health care resources are limited? By Christopher Hartnick Opinion: A former CDC director's guide to seeing and stopping threats to America's health At a time when many feel helpless to stop dangerous changes to vaccine policy, Tom Frieden's new book offers a way forward. By Tom Frieden

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser